Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases

被引：5

作者：

Cany, L ^{[1
]}

Toulouse, C ^{[1
]}

Ravaud, A ^{[1
]}

Durand, M ^{[1
]}

Mauriac, L ^{[1
]}

机构：

[1] INST BERGONIE,REG CANC CTR,DEPT MED,F-33076 BORDEAUX,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 02期

关键词：

D O I：

10.1016/0959-8049(95)00590-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：370 / 371

页数：2

共 6 条

[1]

DIERAS V, 1992, ANN ONCOL, V3, P46

[2]

DIERAS V, 1990, NAVELBINE R ACTUALIT

[3] PHASE-II TRIAL OF WEEKLY INTRAVENOUS VINORELBINE IN 1ST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY [J].

FUMOLEAU, P ;

DELGADO, FM ;

DELOZIER, T ;

MONNIER, A ;

DELGADO, MAG ;

KERBRAT, P ;

GARCIAGIRALT, E ;

KEILING, R ;

NAMER, M ;

CLOSON, MT ;

GOUDIER, MJ ;

CHOLLET, P ;

LECOURT, L ;

MONTCUQUET, P .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1245-1252

[4]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[5]

2-6

[6]

PLATINI C, 1993, P 4 INT C ANT CHEM, P145

← 1 →